Theratechnologies Inc. (THTX)
NASDAQ: THTX · Real-Time Price · USD
1.210
-0.010 (-0.82%)
Nov 21, 2024, 11:40 AM EST - Market open
Theratechnologies Revenue
Theratechnologies had revenue of $22.60M in the quarter ending August 31, 2024, with 8.37% growth. This brings the company's revenue in the last twelve months to $84.32M, up 5.75% year-over-year. In the fiscal year ending November 30, 2023, Theratechnologies had annual revenue of $81.76M with 2.13% growth.
Revenue (ttm)
$84.32M
Revenue Growth
+5.75%
P/S Ratio
n/a
Revenue / Employee
$818,602
Employees
103
Market Cap
55.81M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2023 | 81.76M | 1.71M | 2.13% |
Nov 30, 2022 | 80.06M | 10.23M | 14.66% |
Nov 30, 2021 | 69.82M | 3.77M | 5.71% |
Nov 30, 2020 | 66.05M | 2.84M | 4.49% |
Nov 30, 2019 | 63.22M | 18.00M | 39.81% |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Nov 30, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Procaps Group | 414.10M |
Owlet | 78.61M |
bluebird bio | 53.12M |
Prenetics Global | 22.66M |
DBV Technologies | 12.52M |
THTX News
- 4 weeks ago - Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV - GlobeNewsWire
- 5 weeks ago - Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance - GlobeNewsWire
- 6 weeks ago - Theratechnologies Inc. (THTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024 - GlobeNewsWire
- 6 weeks ago - Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV - GlobeNewsWire
- 2 months ago - Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update - GlobeNewsWire
- 2 months ago - Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025 - GlobeNewsWire
- 2 months ago - Theratechnologies to Present at Upcoming Investor Conferences in September - GlobeNewsWire